Representatives from our Adis BI team recently attended the Advances in Drug Discovery conference, which took place at The Wellcome Genome Campus Conference Centre in Cambridge on 6th and 7th March 2017.
Having previously been focused entirely on academic drug discovery, the conference expanded this year into a multi-track event, with additional streams for Antibodies, Epigenetics and Stem Cells.
A theme throughout many of the sessions, and among delegates, was about collaboration – how can all of the potential partners in drug discovery: pharma, biotech, CROs, regulatory bodies and academia, all work together and share research, and what (possibly changing) role can UK academics play in particular.
Our technology spotlight session on Day 2 looked at the role that a drug database plays in supporting collaborations. Comparisons were drawn between dating in the modern world and the challenges partners in drug discovery face in finding potential collaborators – in both cases your odds of success are greatly increased if you use the same platforms as your potential partners, identify partners with similar interests, and recover quickly from failure. Using industry-standard tools to support academic research is a big step in the right direction, helping researchers to become more efficient, stay up to date and increase their commercialisation power.
Gemma Ryder, Product Marketing Manager for Adis BI, said:
This fairly small-scale but targeted event was a great opportunity for us to speak to the different people involved in academic drug research, and to gain a clearer understanding of the tools and resources they need to support their work. We were able to offer on-the-spot demonstrations at our booth, and to get some valuable feedback about how researchers would use such a platform.
Details for the 2018 conference are still to be released at the time of writing this post, but are expected to be published at https://selectbiosciences.com/conferences.aspx.